Dantari
Thousand Oaks
About Dantari
Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system. The company's platform and therapies specialize in the research and development of small and large molecule therapeutics across the blood-brain barrier, enabling clients to have rapidly advance therapies to treat the patients and provide meaningful medical improvement in their lives.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $47.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2022)
- Website: dantari.com
Industries & Categories
Life Science
Social Profiles
Canonical: https://fsome.com/organization/dantari-39567 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.